Differentiating EPA from EPA/DHA in cardiovascular risk reduction.

Additionally, potential antiplatelet/antithrombotic effects may also play a potential beneficial mechanistic role for CV risk reduction as noted by a nonsignificant trend in increased bleeding events that was not seen in STRENGTH or OMEMI [51] . 4.

also in 5,406 other papers